SCHEMBL715968

SCHEMBL715968

O=C1OCCCOC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL493857 0.92 CA1 (0.53)
SCHEMBL9788227 0.89 CA1 (0.50)
SCHEMBL28886215 0.89 CA1 (0.50)
SCHEMBL28379193 0.89 CA1 (0.50)
SCHEMBL17672300 0.89 CA1 (0.50)
SCHEMBL493682 0.89 CA1 (0.50)
SCHEMBL3093303 0.89 CA1 (0.50)
SCHEMBL31492941 0.89 CA1 (0.50)
SCHEMBL4302406 0.89 CA1 (0.50)
SCHEMBL13243106 0.86 CA1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025111568-A1 LUMATEPERONE AND ANALOGUES, AS 5-HT2A OR 5-HT2A/D2 RECEPTOR MODULATORS, FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS CAUSED BY VIRAL, BACTERIAL, OR AUTOIMMUNE ENCEPHALITIS, AND OF PSYCHIATRIC SYMPTOMS THEREOF INTRA-CELLULAR THERAPIES, INC. (US) 2025-05-30 WO disclosed
EP-4525874-A1 NOVEL METHODS Intra-Cellular Therapies, Inc. (US) 2025-03-26 EP disclosed
EP-4493560-A2 ORGANIC COMPOUNDS Intra-Cellular Therapies, Inc. (US) 2025-01-22 EP disclosed
WO-2023225620-A1 NOVEL METHODS INTRA-CELLULAR THERAPIES, INC. (US) 2023-11-23 WO disclosed
WO-2023178111-A2 ORGANIC COMPOUNDS INTRA-CELLULAR THERAPIES, INC. (US) 2023-09-21 WO disclosed
EP-4072554-A1 ORGANIC COMPOUND Intra-Cellular Therapies, Inc. (US) 2022-10-19 EP disclosed
WO-2021119334-A1 ORGANIC COMPOUND INTRA-CELLULAR THERAPIES, INC. (US) 2021-06-17 WO disclosed
EP-3768254-A1 ORGANIC COMPOUNDS Intra-Cellular Therapies, Inc. (US) 2021-01-27 EP disclosed
EP-3768271-A1 ORGANIC COMPOUNDS Intra-Cellular Therapies, Inc. (US) 2021-01-27 EP disclosed
US-10632079-B2 Microspheres having core/shell structure OTSUKA PHARMACEUTICALS CO., LTD. (JP) 2020-04-28 US disclosed
WO-2001056646-A1 MEDICAL DEVICE ZOUCAS KIRURGKONSULT AB (SE) 2001-08-09 WO disclosed
EP-0891774-A2 Process for producing sustained release preparation Takeda Chemical Industries, Ltd. (JP) 1999-01-20 EP disclosed
EP-0353961-B1 Thermoplastic elastomer-based low vulnerability ammunition gun propellants THIOKOL CORP (US) 1995-12-27 EP disclosed
US-5171784-A Blends of vinyl chloride copolymers, phenoyx resins, hydroxy acrylate or methacrylate lactone adducts and acrylate-diisocyanate adducts; magnetic recording media UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1992-12-15 US disclosed
EP-0375660-A2 Phosphorylated reaction products and compositions incorporating such products UNION CARBIDE CORPORATION (US) 1990-06-27 EP disclosed
US-4919737-A NON-CROSSLINKED, RESIDUE-FREE BINDER CONTAINING AMORPHOUS POLYETHER AND CRYSTALLINE POLYESTER BLOCKS MORTON THIOKOL INC. (US) 1990-04-24 US disclosed
EP-0353961-A2 Thermoplastic elastomer-based low vulnerability ammunition gun propellants THIOKOL CORPORATION (US) 1990-02-07 EP disclosed
EP-0219710-A1 Flexible, self-crosslinking binders UNION CARBIDE CORPORATION (US) 1987-04-29 EP disclosed
EP-0217410-A2 Phosphorylated reaction products and compositions incorporating such products UNION CARBIDE CORPORATION (US) 1987-04-08 EP disclosed
US-4647506-A HYDROXY THERMOPLASTIC RESIN GRAFTED WITH DIISOCYANATE-UNSATURATED ESTER CONDENSATE UNION CARBIDE CORPORATION (US) 1987-03-03 US disclosed